BIRMINGHAM, Ala., and JOHNSTON, R.I., July 30, 2024 /PRNewswire/ -- Today, Encompass Health (NYSE: EHC), the nation's largest owner and operator of rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Johnston, a 50-bed inpatient rehabilitation hospital located at 2109 Hartford Avenue in Johnston, Rhode Island.
The hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients receive a minimum of three hours of intensive therapy for five days each week, frequent physician visits and 24-hour nursing care.
Hospital amenities include private patient rooms, a spacious therapy gym featuring advanced rehabilitation technologies, an activities of daily living suite, in-house dialysis suite, therapy courtyard, dining room, in-house pharmacy and dayroom area. An interdisciplinary team of highly specialized nurses, therapists and physicians provide physical, occupational and speech therapies to restore functional ability and quality of life.
"Our goal is to provide a place where families and patients can access quality care; a place where patients discover hope and regain the confidence to join their community; and most importantly, a place where patients regain the independence that results in a better quality of life," said Pat Tuer, Encompass Health Group President. "We are honored to say that currently one in three patients receiving inpatient rehabilitation care in the country receives it through an Encompass Health hospital, and we're excited to serve Rhode Island patients close to home in the Johnston community."
To learn more, visit encompasshealth.com/locations/johnstonrehab.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 164 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Becker's Hospital Review's 150 Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Encompass Health media contact:
Polly Manuel | 205-970-5912
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$103.35 |
Daily Change: | 0.35 0.34 |
Daily Volume: | 986,848 |
Market Cap: | US$10.410B |
December 18, 2024 November 04, 2024 October 28, 2024 August 05, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load